Filing Flows › Carlsmed (CARL) › Q2 2026 › vs Q2 2025
Carlsmed (CARL) Q2 2026 vs Q2 2025 (year over year)
Carlsmed's revenue rose $6.9M (+57%) from $12.1M in Q2 2025 to $18.9M in Q2 2026.
Carlsmed, Q2 2026: revenue $18.9M (+57% year over year), operating margin -58.3%, net loss $10.5M, operating cash flow −$7.4M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $18.9M | $12.1M | $6.9M | +57% |
| Other income, net | $526K | −$264K | $790K | — |
| Net loss | $10.5M | $6.8M | $3.7M | +55% |
| Costs & expenses | $30.0M | $18.8M | $11.1M | +59% |
| Operating costs | $30.0M | $18.6M | $11.4M | +61% |
| Cost of revenue | $4.4M | $3.2M | $1.2M | +37% |
| Research & development | $6.0M | $4.2M | $1.9M | +45% |
| Sales & marketing | $11.9M | $7.9M | $4.1M | +51% |
| General & admin | $7.6M | $3.3M | $4.3M | +128% |
| Operating cash sources | $10.5M | $6.8M | $3.7M | +55% |
| Depreciation & amortization | $130K | $61K | $69K | +113% |
| Share-based compensation | $2.3M | $258K | $2.0M | +780% |
| Working capital & other | $751K | −$595K | $1.3M | — |
| Cash used in operations | $7.4M | $7.0M | $316K | +4% |
| Net loss absorbed | $10.5M | $6.8M | $3.7M | +55% |
Questions
How much did Carlsmed's revenue grow year over year in Q2 2026?
Carlsmed's revenue rose $6.9M (+57%) from $12.1M in Q2 2025 to $18.9M in Q2 2026.